Reduced histone deacetylase in COPD: clinical implications.
about
Epigenetic: A missing paradigm in cellular and molecular pathways of sulfur mustard lung: a prospective and comparative studyEndoplasmic reticulum stress and the related signaling networks in severe asthmaGenomic impact of cigarette smoke, with application to three smoking-related diseasesGene expression profile and toxic effects in human bronchial epithelial cells exposed to zearalenoneLong-term effects of acupuncture treatment on airway smooth muscle in a rat model of smoke-induced chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease: a growing but neglected global epidemicSecretion of the endoplasmic reticulum stress protein, GRP78, into the BALF is increased in cigarette smokers.Epigenetics and chromatin remodeling play a role in lung diseaseChanges in airway histone deacetylase2 in smokers and COPD with inhaled corticosteroids: a randomized controlled trialSurgical and bronchoscopic lung volume reduction in chronic obstructive pulmonary disease.Nitric oxide sustains IL-1β expression in human dendritic cells enhancing their capacity to induce IL-17-producing T-cells.Interleukin-1beta induces increased transcriptional activation of the transforming growth factor-beta-activating integrin subunit beta8 through altering chromatin architectureImmunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification.Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study.Treatment with 1,25(OH)2D3 induced HDAC2 expression and reduced NF-κB p65 expression in a rat model of OVA-induced asthma.Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?Phosphodiesterase 4 inhibitors in chronic obstructive pulmonary disease: a new approach to oral treatment.HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity.Regulation of Wnt4 in chronic obstructive pulmonary disease.Differentiating COPD from asthma in clinical practice.Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease.Mechanisms of cigarette smoke-induced COPD: insights from animal models.Treating COPD with PDE 4 inhibitors.Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease.Histone deacetylase-2 and airway disease.Epigenetic Regulation of Interleukin 6 by Histone Acetylation in Macrophages and Its Role in Paraquat-Induced Pulmonary Fibrosis.The Saudi Guidelines for the Diagnosis and Management of COPD.Challenges of treating asthma in people who smoke.Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.Role of transcription factors in the pathogenesis of asthma and COPD.Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease.The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice.The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease.A prospective randomized controlled study: Theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients.Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression.Effects of smoking cessation on lung function and airway inflammation in smokers with asthma.Bone Marrow-Derived Mononuclear Cell Therapy in Papain-Induced Experimental Pulmonary Emphysema.Individualized treatment for asthma
P2860
Q26777648-E9CB5343-C521-4E8C-B13F-D83B6D362311Q27001541-18CB44E8-64CA-4559-BDAE-DDA8786FEF70Q27027763-A938AA32-0031-48C0-A3AD-17BFC775F514Q28538432-8ACC90BB-549E-4E41-B14F-B78B75312E60Q30378871-A7B444D6-26E8-4461-B48D-D5B7925719BFQ33284699-A206687A-0B6B-4F8C-A72F-142F79FCB347Q33629638-91B49F36-2921-4BE6-B9D3-AF7BD9A6555DQ34126445-2E261CB1-237A-403D-8FEA-31424F214420Q34746429-C2C1F05F-3826-45F1-AC1C-513ED44FBF8FQ34966332-7308284E-839E-4C18-A84D-B0F71EB86CD4Q35327027-9C207C58-9DFE-443A-AB9E-EC193401771DQ35378909-13C68B39-7B58-4155-94BF-8B394BFA1323Q35542366-B1FEF3E6-DD32-431B-B79A-C57C5A74708FQ35835849-06DE8F22-5F42-43D6-8903-091674B07079Q35881358-63DCC5C8-C4A8-43E4-B4C8-6443B5485C5FQ36654923-9F4C78EA-39B6-4625-B312-4F7EF0B42E84Q36792648-6FAC8B91-66BB-4420-B0C0-29789C9A47E6Q36834101-0FC91832-D5DB-49B6-B279-E430745DB039Q36860267-75B15230-1DC3-4DD4-97A4-4DE0665A456BQ36951507-B03B6BE0-55F0-45F2-8284-61A9F77E1EC0Q36956720-D3D9808D-D831-4A87-8FA8-D25F3928E832Q37068538-EF49B59D-EA34-4867-BB50-746D26AC5351Q37082594-982A526A-9376-43FB-ABB0-8AC0CD7E2C59Q37153293-03324C0B-E3FA-4A66-969C-41CC684AFBCBQ37610653-89C68748-3D89-4AC7-A40C-B9C4D0D0BD8DQ37611647-E570C0B3-EE4B-4E65-AE31-D6627CC2CB42Q37733309-A5CF6D21-560A-49F6-B4B6-A2BD843CFEDCQ37733518-FE85BB5E-10A3-462A-9A19-D3DDE0C98611Q38076074-4469CD06-619A-4E37-9494-C5613953A706Q38087650-A33BC024-243C-4AD6-B549-AC6AEFB74F6DQ38213677-1FB3B336-C0E5-4D78-8417-63D7E491026DQ38710985-6EE14307-4C25-49C7-A5E5-066CD5A266C6Q38827675-AD8E9262-A154-4CDA-A898-561113DAB8A6Q39956452-57BE1FCC-6392-4472-ADAB-4CF874B042ABQ42942210-2433713D-67D6-4DBC-94B2-29666014B378Q47169782-239E3FC9-7F32-4D1F-BE24-5F43643DF239Q48189418-169FA954-9097-4F26-90C1-454990DEDEA7Q53625416-0049D3BB-BEED-40AE-841C-363A00FEC491Q54974180-F3255DDD-D4D7-4881-9937-026A7F134F1DQ57786134-55B04B00-CC1B-423E-83FC-918AF4B5DCC8
P2860
Reduced histone deacetylase in COPD: clinical implications.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Reduced histone deacetylase in COPD: clinical implications.
@ast
Reduced histone deacetylase in COPD: clinical implications.
@en
type
label
Reduced histone deacetylase in COPD: clinical implications.
@ast
Reduced histone deacetylase in COPD: clinical implications.
@en
prefLabel
Reduced histone deacetylase in COPD: clinical implications.
@ast
Reduced histone deacetylase in COPD: clinical implications.
@en
P356
P1433
P1476
Reduced histone deacetylase in COPD: clinical implications.
@en
P2093
Peter J Barnes
P304
P356
10.1378/CHEST.129.1.151
P407
P577
2006-01-01T00:00:00Z